0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe
Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.
Start free with EleplanClinical drug
0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe
50 MG/ML · Prefilled Syringe · injection
A form of adalimumab-aqvh →
0.8 ML adalimumab-aqvh 50 MG/ML Prefilled Syringe — Tumor necrosis factor alpha (TNF-alpha) inhibitors. Strength, form, class, interactions & more.
Active ingredient
Classification
Tumor necrosis factor alpha (TNF-alpha) inhibitorsTumor Necrosis Factor Blocker
Drug interactions
Adalimumab-aqvh has several drug interactions that may increase the risk of serious infections or require monitoring of other medications.
- majorabatacept — Increased risk of serious infection
- majoranakinra — Increased risk of serious infection
- majorlive vaccines — Avoid use
- moderateCYP450 substrates with a narrow therapeutic index (e.g., warfarin, cyclosporine, theophylline) — Monitoring of effect or drug concentration is recommended
Real-world adverse events (FAERS)
Accidental Exposure to Product34Product Dose Omission Issue31Device Malfunction26No Adverse Event14Device Leakage9Product Quality Issue9Product Complaint6Drug Ineffective5
Source: RxNorm + openFDA + RxClass + FAERS · 2026
Look up another medication